Cargando…
Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
Anastrozole is an orally active, non-steroidal aromatase inhibitor which appears effective as neoadjuvant treatment of breast cancer. Histological changes have been evaluated in biopsies from large, oestrogen-receptor rich, operable breast tumours in postmenopausal women following 12 weeks of neoadj...
Autores principales: | Anderson, T J, Dixon, J M, Stuart, M, Sahmoud, T, Miller, W R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364231/ https://www.ncbi.nlm.nih.gov/pubmed/12177804 http://dx.doi.org/10.1038/sj.bjc.6600435 |
Ejemplares similares
-
Anastrozole (‘Arimidex’) blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer
por: Miller, W R, et al.
Publicado: (2002) -
High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours
por: Lillington, D M, et al.
Publicado: (2002) -
Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003) -
Intra-tumoural microvessel density in human solid tumours
por: Hasan, J, et al.
Publicado: (2002) -
The embedded tumour: host physiology is important for the evaluation of tumour growth
por: van Leeuwen, I M M, et al.
Publicado: (2003)